IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo

Posted on | Posted on John Murphy | Leave a Comment on IL-13 decreases susceptibility to airway epithelial SARS-CoV-2 infection but increases disease severity in vivo

Shreya Ghimire, Biyun Xue, Kun Li, Ryan M Gannon, et. al.doi: https://doi.org/10.1101/2024.07.03.60194 Abstract Treatments available to prevent progression of virus-induced lung diseases, including coronavirus disease 2019 (COVID-19) are of limited benefit once respiratory failure occurs. The efficacy of approved and emerging cytokine signaling-modulating antibodies is variable and is affected by disease course and patient-specific inflammation patterns. Therefore, understanding the role of inflammation on the […]

Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Spatial transcriptomics unveils the in situ cellular and molecular hallmarks of the lung in fatal COVID-19

Carlos Garcia-Prieto, Eva Musulen, Veronica Davalos,  et. al.doi: https://doi.org/10.1101/2024.07.03.601404 00010010 Abstract Severe Coronavirus disease 2019 (COVID-19) induces heterogeneous and progressive diffuse alveolar damage (DAD) highly disrupting lung tissue architecture and homeostasis, hampering disease management and leading to fatal outcomes. Characterizing DAD pathophysiology across disease progression is of ultimate importance to better understand the molecular and cellular features driving different DAD patterns and […]

Pfizer Infringed On Moderna Patent With COVID-19 Vaccine: Court

Posted on | Posted on John Murphy | Leave a Comment on Pfizer Infringed On Moderna Patent With COVID-19 Vaccine: Court

JUL 05, 2024 – 07:00 PM, Authored by Zachary Stieber via The Epoch Times, Pfizer and BioNTech’s COVID-19 vaccine infringed on a patent held by rival Moderna, the High Court in London, England, found in a decision released on July 2. The Pfizer-BioNTech and Moderna COVID-19 vaccines both utilize messenger ribonucleic acid (mRNA) technology. Moderna […]

‘Visionary’ study finds inflammation, evidence of Covid virus years after infection

Posted on | Posted on John Murphy | Leave a Comment on ‘Visionary’ study finds inflammation, evidence of Covid virus years after infection

By Isabella Cueto, 2024 Stat Reporting Remember when we thought Covid was a two-week illness? So does Michael Peluso, assistant professor of medicine at the University of California, San Francisco.  He recalls the rush to study acute Covid infection, and the crush of resulting papers. But Peluso, an HIV researcher, knew what his team excelled at: following […]

COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised

Posted on | Posted on John Murphy | Leave a Comment on COVID-19 and spinal cord injury: clinical presentation, clinical course, and clinical outcomes of people hospitalised

Inge E. Eriks-Hoogland, Michael A. Barth, Lorena L. Müller, et. al. Spinal Cord Series and Cases volume 10, Article number: 5 (2024)  Abstract Study design Retrospective study Objectives To describe the presenting symptoms/signs, clinical course and outcomes in hospitalised people with spinal cord injury (SCI) and symptomatic COVID-19 infections. Setting One university hospital and two SCI centres in Switzerland. Methods Descriptive analysis of […]

Acute Transverse Myelitis (ATM): An Unexpectedly Frequent Complication of COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Acute Transverse Myelitis (ATM): An Unexpectedly Frequent Complication of COVID-19

Todd Ackerman A Houston Methodist-led team of researchers have found COVID-19 can result in an unexpectedly frequent occurrence of acute transverse myelitis (ATM), a rare but often devastating spinal cord disorder. The team’s study of documented pandemic cases found that 43 involved ATM, an inflammation of the spinal cord that prevents sensory and motor information […]

Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19

Posted on | Posted on John Murphy | Leave a Comment on Rapid Dissemination of Protocols for Managing Neurology Inpatients with COVID-19

Authors: Anna Cervantes-Arslanian MD,K. H. Vincent Lau MD,Pria Anand MD, et. al. Annals of Neurology Volume 88, Issue 2 p. 211-214 Introduction In response to the coronavirus disease 2019 (COVID-19) pandemic, the scientific community has made great efforts to accelerate its process for knowledge synthesis and dissemination, including expedited journal peer review,1 open source platforms for quick […]

Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study

Posted on | Posted on John Murphy | Leave a Comment on Prevalence and patterns of symptoms of dysautonomia in patients with long-COVID syndrome: A cross-sectional study

Authors: Ahmed M. Eldokla,Aliae A. Mohamed-Hussein, Ahmed M. Fouad, et. al. 08 Annals of Clinical and Translational Neurology Volume 9, Issue 6 p. 778-785 Abstract Background The association between autonomic dysfunction and long-COVID syndrome is established. However, the prevalence and patterns of symptoms of dysautonomia in long-COVID syndrome in a large population are lacking. Objective To […]

Researchers discover new key protection against COVID-19 in saliva

Posted on | Posted on John Murphy | Leave a Comment on Researchers discover new key protection against COVID-19 in saliva

Authors: Reviewed by Emily Henderson, B.Sc. Jul 19 2022 Medical Science News An Osaka Metropolitan University research group led by Associate Professor Misako Matsubara of the Department of Veterinary Science, Graduate School of Veterinary Science, and Specially Appointed Professor Katsutoshi Yoshizato of the Department of Hepatology, Graduate School of Medicine, suspected that the innate immune system […]

Transient visual field loss after COVID-19 vaccination: Experienced by ophthalmologist, case report

Posted on | Posted on John Murphy | Leave a Comment on Transient visual field loss after COVID-19 vaccination: Experienced by ophthalmologist, case report

Authors: Chaisiri JumroendararasameSomboon PanyakornRittirak OthongAuraya JumroendararasameWorapot SrimananKun Tipparut12345678910 American Journal of Opthalmology A B S T R A C TPurpose: The first reported case of bilateral transient visual field defect, experienced by an ophthalmologist, which developed shortly after COVID-19 vaccination (CoronaVac, Sinovac Biotech Ltd., Beijing, China) and confirmed by computerized automated perimetry.Observation: The patient is […]